The hematopoietic stem cell transplantation (HSCT) market has witnessed substantial growth in the recent years owing to the rising prevalence of various blood cancers such as leukemia, lymphoma and multiple myeloma. HSCT involves transplantation of healthy stem cells to replace a patient's diseased bone marrow. It is often used as a treatment option for patients who have received high-doses of chemotherapy and/or radiation therapy to treat various cancers. The global HSCT procedure volume has increased significantly over the past decade, driving demand for stem cell collection, processing and cryopreservation products.

The Global Hematopoietic stem cell transplantation (HSCT) Market is estimated to be valued at US$ 15.26 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.

Get More Insights On Hematopoietic stem cell transplantation (HSCT) market

https://www.zupyak.com/p/4...